Baidu
map

2016 CCO指南:头颈部鳞状细胞癌的系统治疗

2016-08-10 加拿大安大略癌症治疗中心 CCO官网

2016年8月,加拿大安大略癌症治疗中心(CCO)发布了头颈部鳞状细胞癌的系统治疗指南。

中文标题:

2016 CCO指南:头颈部鳞状细胞癌的系统治疗

英文标题:

Systemic Therapy in the Curative Treatment of Head and Neck Squamous Cell Cancer

发布日期:

2016-08-10

简要介绍:

2016年8月,加拿大安大略癌症治疗中心(CCO)发布了头颈部鳞状细胞癌的系统治疗指南,该指南的目的是基于关于局部晚期头颈部非转移性鳞状细胞癌治疗策略的RCT试验数据,提供推荐建议。拓展指南:头颈部鳞状细胞癌相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2016 CCO指南:头颈部鳞状细胞癌的系统治疗)] GetToolGuiderByIdResponse(projectId=1, id=5a1f11c00132661b, title=2016 CCO指南:头颈部鳞状细胞癌的系统治疗, enTitle=Systemic Therapy in the Curative Treatment of Head and Neck Squamous Cell Cancer, guiderFrom=CCO官网, authorId=null, author=, summary=2016年8月,加拿大安大略癌症治疗中心(CCO)发布了头颈部鳞状细胞癌的系统治疗指南。, cover=, journalId=null, articlesId=null, associationId=13, associationName=加拿大安大略癌症治疗中心, associationIntro=加拿大安大略癌症治疗中心(CCO,Cancer Care Ontario)是致力于不断改善癌症服务的省级机构,同时为政府的癌症顾问,主要任务包括指导和监督医院和其他组织提供高质量及时的癌症服务;执行省级的癌症预防和筛查方案;与专业人员和组织一起制定和实施质量改进和标准;推进癌症临床实践的改进和创新等等。, copyright=0, guiderPublishedTime=Wed Aug 10 00:00:00 CST 2016, originalUrl=, linkOutUrl=, content=<span style="text-indent: 28px;">2016年8月,加拿大安大略癌症治疗中心(CCO)发布了头颈部鳞状细胞癌的系统治疗指南,</span><span style="margin: 0em; padding: 0px; text-indent: 2em;">该指南的目的是基于关于局部晚期头颈部非转移性鳞状细胞癌治疗策略的RCT试验数据,提供推荐建议。</span>拓展指南:<strong>与<font color=red>头颈部鳞状细胞癌</font>相关指南:</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=0e4e91c0012e1615" title="2016 头颈部鳞状细胞癌颈淋巴结转移处理的专家共识" target=_blank>2016 头颈部鳞状细胞癌颈淋巴结转移处理的专家共识</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=793a31c001220ade" title="头颈部鳞状细胞癌颈淋巴结转移处理的专家共识" target=_blank>头颈部鳞状细胞癌颈淋巴结转移处理的专家共识</a></li> 更多信息请点击:<a href="//m.capotfarm.com/guideline/list.do?q=%E5%A4%B4%E9%A2%88%E9%83%A8%E9%B3%9E%E7%8A%B6%E7%BB%86%E8%83%9E%E7%99%8C" target=_blank>有关头颈部鳞状细胞癌更多指南</a></ul>, tagList=[TagDto(tagId=26398, tagName=头颈部鳞状细胞癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=73, categoryName=头颈外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=4, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6338, appHits=163, showAppHits=0, pcHits=4480, showPcHits=2597, likes=146, shares=7, comments=4, approvalStatus=1, publishedTime=Fri Nov 11 10:08:59 CST 2016, publishedTimeString=2016-08-10, pcVisible=1, appVisible=1, editorId=88252, editor=jingwen, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=jingwen, createdTime=Fri Nov 11 10:08:59 CST 2016, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 14:31:28 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2016 CCO指南:头颈部鳞状细胞癌的系统治疗)])
2016 CCO指南:头颈部鳞状细胞癌的系统治疗
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=157522, encodeId=c7f415e522a5, content=I make a great progress I have gained a lot, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Tue Nov 22 21:34:56 CST 2016, time=2016-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=156343, encodeId=480a15634321, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160304/IMG56D94856B1B5D6405.jpg, createdBy=27931687771, createdName=一个字-牛, createdTime=Thu Nov 17 09:56:05 CST 2016, time=2016-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=156270, encodeId=ea4f1562e00d, content=这篇咨询不错哦,值得学习,对于临床工作和科研思路都很有帮助。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Thu Nov 17 07:47:48 CST 2016, time=2016-11-17, status=1, ipAttribution=)]
    2016-11-22 zibozhouping

    I make a great progress I have gained a lot

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=157522, encodeId=c7f415e522a5, content=I make a great progress I have gained a lot, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Tue Nov 22 21:34:56 CST 2016, time=2016-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=156343, encodeId=480a15634321, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160304/IMG56D94856B1B5D6405.jpg, createdBy=27931687771, createdName=一个字-牛, createdTime=Thu Nov 17 09:56:05 CST 2016, time=2016-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=156270, encodeId=ea4f1562e00d, content=这篇咨询不错哦,值得学习,对于临床工作和科研思路都很有帮助。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Thu Nov 17 07:47:48 CST 2016, time=2016-11-17, status=1, ipAttribution=)]
    2016-11-17 一个字-牛

    值得学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=157522, encodeId=c7f415e522a5, content=I make a great progress I have gained a lot, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Tue Nov 22 21:34:56 CST 2016, time=2016-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=156343, encodeId=480a15634321, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160304/IMG56D94856B1B5D6405.jpg, createdBy=27931687771, createdName=一个字-牛, createdTime=Thu Nov 17 09:56:05 CST 2016, time=2016-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=156270, encodeId=ea4f1562e00d, content=这篇咨询不错哦,值得学习,对于临床工作和科研思路都很有帮助。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Thu Nov 17 07:47:48 CST 2016, time=2016-11-17, status=1, ipAttribution=)]
    2016-11-17 李东泽

    这篇咨询不错哦,值得学习,对于临床工作和科研思路都很有帮助。

    0

Baidu
map
Baidu
map
Baidu
map